0

Journal Articles

in Neurology
 521-540 of 586 Articles
Original Investigation |  FREE
Timothy M. E. Davis, FRACP; Helen Millns, PhD; Irene M. Stratton, MsC; et al.
Arch Intern Med. 1999;159(10):1097-1103. doi:10.1001/archinte.159.10.1097.

Original Investigation |  FREE
Stephen L. Kopecky, MD; Bernard J. Gersh, MB, ChB, DPhil; Michael D. McGoon, MD; et al.
Arch Intern Med. 1999;159(10):1118-1122. doi:10.1001/archinte.159.10.1118.

Editor's Correspondence | 
Charles E. Schwartz, MD
Arch Intern Med. 1999;159(10):1141. doi:.

Editor's Correspondence | 
Thomas J. Romano, MD, PhD
Arch Intern Med. 1999;159(9):1008. doi:.

Editor's Correspondence | 
Fredric Gerr, MD; Michele Marcus, PhD
Arch Intern Med. 1999;159(9):1008-1009. doi:.

Editor's Correspondence | 
Steven G. Atcheson, MD
Arch Intern Med. 1999;159(9):1009-1010. doi:.

Editor's Correspondence | 
Jeffrey T. Kuvin, MD
Arch Intern Med. 1999;159(9):1011. doi:.

Editor's Correspondence | 
Montserrat Fuster, MD; Eugenia Negredo, MD; Josep Cadafalch, MD; et al.
Arch Intern Med. 1999;159(9):1012. doi:.

Autopsy and Medicine | 
Randy Hanzlick, MD; Jesse K. McKenney, MD; Autopsy Committee of the College of American Pathologists
Arch Intern Med. 1999;159(9):907-908. doi:10.1001/archinte.159.9.907.

Original Investigation |  FREE
Naomi R. Kramer, MD; Thorley E. Cook, DO; Carol C. Carlisle, RN; et al.
Arch Intern Med. 1999;159(9):965-968. doi:10.1001/archinte.159.9.965.

Original Investigation |  FREE
Tom Rea, MD; Joan Russo, PhD; Wayne Katon, MD; et al.
Arch Intern Med. 1999;159(8):865-870. doi:10.1001/archinte.159.8.865.

Original Investigation |  FREE
Didier Pittet, MD, MS; Blaise Wyssa, MD; Catherine Herter-Clavel, MD; et al.
Arch Intern Med. 1999;159(8):851-856. doi:10.1001/archinte.159.8.851.

Original Investigation |  FREE
Jennifer H. Lofland, PharmD; Nelda E. Johnson, PharmD; Alice S. Batenhorst, PharmD; et al.
Arch Intern Med. 1999;159(8):857-863. doi:10.1001/archinte.159.8.857.

Original Investigation |  FREE
X. Henry Hu, MD, MPH, PhD; Leona E. Markson, ScD; Richard B. Lipton, MD; et al.
Arch Intern Med. 1999;159(8):813-818. doi:10.1001/archinte.159.8.813.

Review Article |  FREE
Stephanie S. Richards, MD; Hugh C. Hendrie, MB, ChB
Arch Intern Med. 1999;159(8):789-798. doi:10.1001/archinte.159.8.789.

Review Article |  FREE
Don L. Goldenberg, MD
Arch Intern Med. 1999;159(8):777-785. doi:10.1001/archinte.159.8.777.

Original Investigation |  FREE
Malcolm Man-Son-Hing, MD, MSc, FRCPC; Graham Nichol, MD, MPH, FRCPC; Anita Lau; et al.
Arch Intern Med. 1999;159(7):677-685. doi:10.1001/archinte.159.7.677.

Original Investigation |  FREE
Cornelia M. Weyand, MD; James W. Fulbright, MS; Jonathan M. Evans, MD; et al.
Arch Intern Med. 1999;159(6):577-584. doi:10.1001/archinte.159.6.577.

Original Investigation |  FREE
Mariam Avakian Manoukian, MD; Julie A. Foote, MD; Lawrence M. Crapo, MD, PhD
Arch Intern Med. 1999;159(6):601-606. doi:10.1001/archinte.159.6.601.

Editor's Correspondence | 
Myron L. Cohen, PhD; Alan S. Berson, PhD; Bruce Alpert, MD; et al.
Arch Intern Med. 1999;159(4):407. doi:.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Editorial  | 
Real-world Experience in the Midst of an Exserohilum Meningitis Outbreak
George R. Thompson, MD; Dimitrios P. Kontoyiannis, MD; Thomas F. Patterson, MD
JAMA
Original Contribution  | 
Time to Treatment With Intravenous Tissue Plasminogen Activator and Outcome From Acute Ischemic Stroke
Jeffrey L. Saver, MD; Gregg C. Fonarow, MD; Eric E. Smith, MD, MPH; et al.
JAMA
News From the Centers for Disease Control and Prevention  | 
Persistent Obstacles Mar Progress in Eradicating Polio

JAMA Neurology
Observation  | 
Successful Treatment of Anti-Caspr2 Syndrome by Interleukin 6 Receptor Blockade Through Tocilizumab
Christos Krogias, MD; Robert Hoepner, MD; Andre Müller, MD; et al.